HK1138181A1 - 免疫調節劑、含有免疫調節劑的組合物及其用途 - Google Patents
免疫調節劑、含有免疫調節劑的組合物及其用途Info
- Publication number
- HK1138181A1 HK1138181A1 HK10103400.6A HK10103400A HK1138181A1 HK 1138181 A1 HK1138181 A1 HK 1138181A1 HK 10103400 A HK10103400 A HK 10103400A HK 1138181 A1 HK1138181 A1 HK 1138181A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- immune modulators
- compositions including
- modulators
- including immune
- immune
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
- G01N2333/70514—CD4
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Developmental Biology & Embryology (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84834806P | 2006-09-29 | 2006-09-29 | |
US11/855,944 US10471100B2 (en) | 2006-09-29 | 2007-09-14 | Nanofraction immune modulators, preparations and compositions including the same, and associated methods |
PCT/US2007/078947 WO2008042604A2 (en) | 2006-09-29 | 2007-09-19 | Immune modulators, preparations and compositions including immune modulators, tests for evaluating the activity of immune modulators and preparations and compositions including the same, and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1138181A1 true HK1138181A1 (zh) | 2010-08-20 |
Family
ID=39261440
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10103400.6A HK1138181A1 (zh) | 2006-09-29 | 2010-04-07 | 免疫調節劑、含有免疫調節劑的組合物及其用途 |
Country Status (15)
Country | Link |
---|---|
US (2) | US10471100B2 (zh) |
EP (1) | EP2068913B1 (zh) |
JP (3) | JP5592651B2 (zh) |
CN (1) | CN101553247B (zh) |
AU (1) | AU2007305076B2 (zh) |
CO (1) | CO6220833A2 (zh) |
EC (1) | ECSP099296A (zh) |
ES (1) | ES2658107T3 (zh) |
HK (1) | HK1138181A1 (zh) |
MX (1) | MX2009003324A (zh) |
MY (2) | MY158857A (zh) |
RU (2) | RU2518341C2 (zh) |
SG (1) | SG160430A1 (zh) |
TW (1) | TWI449530B (zh) |
WO (1) | WO2008042604A2 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11197894B2 (en) | 2006-09-29 | 2021-12-14 | 4Life Patents, Llc | Nanofraction immune modulators, preparations and compositions including the same, and associated methods |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6866868B1 (en) * | 2003-09-15 | 2005-03-15 | 4Life Research, Lc | Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions |
US9028882B2 (en) | 2005-05-02 | 2015-05-12 | 4Life Patents, Llc | Nutraceutical gels |
EP1888090B1 (en) * | 2005-05-02 | 2017-11-22 | 4Life Patents, LLC | Transfer factor preparations and associated methods |
US20100297663A1 (en) * | 2009-05-05 | 2010-11-25 | 4Life Patents, Llc | Methods and systems for assaying, maintaining, and enhancing the activity of the immune system of a subject |
MX340019B (es) | 2010-11-23 | 2016-06-22 | Pantheryx Inc | Composiciones y metodos para el tratamiento en aplicaciones clinicas de amplio espectro, no diferenciadas o combinadas. |
CN102172360B (zh) * | 2011-02-17 | 2013-04-24 | 南京大学 | 一种牛初乳提取物及其提取方法和应用 |
WO2013039373A2 (es) * | 2011-09-13 | 2013-03-21 | Zepeda Lopez Hector Manuel | Extracto dializado de leucocitos de origen bazo de tiburón, para la obtención de factor de transferencia potencializado, y método de extracción, comprobación y conteo del mismo |
WO2013039374A2 (es) * | 2011-09-15 | 2013-03-21 | Zepeda Lopez Hector Manuel | Método de extracción, comprobación y conteo de extracto dializado de leucocitos de origen bazo de tiburón, para la obtención de factor de transferencia potencializado, específicamente diseñado para su uso como tratamiento contra la enfermedad conocida como vitíligo |
WO2013043032A2 (es) * | 2011-09-19 | 2013-03-28 | Zepeda Lopez Hector Manuel | Extracto dializado de leucocitos de origen bazo de tiburón para la obtención de factor de transferencia potencializado, específicamente diseñado para su uso como inmunomodulador y método de extracción, comprobación y conteo del mismo |
WO2013043033A2 (es) * | 2011-09-19 | 2013-03-28 | Zepeda Lopez Hector Manuel | Método de extracción, comprobacíon de extracto dializado de leucocitos de origen bazo de tiburón, para la obtención de factor de transferecia potencializado, específicamente diseñado para su uso como adyuvante potencializador de vacunas virales |
WO2013058640A2 (es) * | 2011-10-20 | 2013-04-25 | Zepeda Lopez Hector Manuel | Método de extracción, comprobación y conteo de extracto dializado de leucocitos de origen bazo de tiburón, para la obtención de factor de transferencia potencializado, específicamente diseñado para su uso como tratamiento contra la enfermedad conocida como asma |
MX338863B (es) * | 2011-12-16 | 2016-05-01 | Inst Politecnico Nacional | Metodo de obtencion de extracto dializable de leucocitos. |
WO2015054694A2 (en) | 2013-10-13 | 2015-04-16 | 4Life Patents, Llc | Therapeutic compositions and methods for addressing physiological stresses and aging |
KR101597540B1 (ko) * | 2014-01-22 | 2016-02-29 | 건국대학교 산학협력단 | 난황 추출물을 유효성분으로 함유하는 면역증강용 조성물 |
US11578371B2 (en) | 2017-06-15 | 2023-02-14 | Mira Dx, Inc. | Biomarkers for predicting tumor response to and toxicity of immunotherapy |
US10933097B1 (en) | 2020-03-05 | 2021-03-02 | King Saud University | Method of treating a bacterial infection using colostrum |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4402938A (en) * | 1980-05-29 | 1983-09-06 | Impro Products, Inc. | Food and the method of extracting the same from colostrum and milk |
JPS60208919A (ja) * | 1983-11-25 | 1985-10-21 | アムトロン・インコ−ポレイテツド | トランスフア−フアクタ−を初乳から得る方法、こうして得られたトランスフア−フアクタ−及びその使用 |
US4816563A (en) * | 1983-11-25 | 1989-03-28 | Amtron, Inc. | Process for obtaining transfer factor from colostrum, transfer factor so obtained and use thereof |
US5585098A (en) * | 1993-11-23 | 1996-12-17 | Ovimmune, Inc. | Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants |
EP1019546B1 (en) * | 1996-03-26 | 2004-12-15 | Cylex, Inc. | Methods for measurement of lymphocyte function |
AU2332997A (en) | 1996-03-26 | 1997-10-17 | Dcv Biologics L.P. | Egg anti-inflammatory composition, method of isolation and use |
US7169571B2 (en) * | 1997-09-12 | 2007-01-30 | Cylex, Inc. | Methods for measurement of lymphocyte function |
CZ287956B6 (cs) * | 1997-11-04 | 2001-03-14 | Medipharm Cz, S. R. O. | Perorální přípravek k prevenci a léčbě parvovirózy psů |
US20020044942A1 (en) * | 2000-09-18 | 2002-04-18 | Chisolm Biological Laboratory, Llc | Transfer factor composition and process for producing same |
US6468534B1 (en) | 2000-09-21 | 2002-10-22 | 4Life Research, Lc | Methods for obtaining transfer factor from avian sources, compositions including avian-generated transfer factor, and methods of use |
US20040101511A1 (en) | 2000-11-08 | 2004-05-27 | Young Aiping H | Combination preparation of a biological response modifier and an anticancer agent and uses thereof |
US20030003117A1 (en) * | 2001-06-18 | 2003-01-02 | Michael Marenick | Hydrolyzed whole egg products & related methods |
MXPA04007694A (es) * | 2002-02-11 | 2004-11-10 | Arkion Life Sciences Llc | Factor inhibidor de citosina purificada. |
US20040005327A1 (en) * | 2002-05-16 | 2004-01-08 | Subramanian Iyer | Immune T-cell stimulation |
WO2004041071A2 (en) | 2002-11-04 | 2004-05-21 | 4Life Research, Lc | Compositions, systems, and methods for focusing a cell-mediated immune response |
CN1460522A (zh) | 2003-06-16 | 2003-12-10 | 郭占军 | 预防和治疗疾病的蛋黄抗体组合物及其制备方法 |
US6866868B1 (en) | 2003-09-15 | 2005-03-15 | 4Life Research, Lc | Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions |
US10471100B2 (en) | 2006-09-29 | 2019-11-12 | 4Life Patents, Llc | Nanofraction immune modulators, preparations and compositions including the same, and associated methods |
CN100502674C (zh) | 2005-10-13 | 2009-06-24 | 复旦大学 | 一种牛初乳和香菇提取物组合物及其制备方法和用途 |
-
2007
- 2007-09-14 US US11/855,944 patent/US10471100B2/en active Active
- 2007-09-19 EP EP07814934.1A patent/EP2068913B1/en active Active
- 2007-09-19 CN CN200780039690.XA patent/CN101553247B/zh active Active
- 2007-09-19 RU RU2009116274/15A patent/RU2518341C2/ru active
- 2007-09-19 MX MX2009003324A patent/MX2009003324A/es active IP Right Grant
- 2007-09-19 MY MYPI20091276A patent/MY158857A/en unknown
- 2007-09-19 ES ES07814934.1T patent/ES2658107T3/es active Active
- 2007-09-19 SG SG201001981-8A patent/SG160430A1/en unknown
- 2007-09-19 WO PCT/US2007/078947 patent/WO2008042604A2/en active Application Filing
- 2007-09-19 AU AU2007305076A patent/AU2007305076B2/en active Active
- 2007-09-19 JP JP2009530527A patent/JP5592651B2/ja active Active
- 2007-09-27 TW TW096135902A patent/TWI449530B/zh active
-
2009
- 2009-03-27 MY MYPI2013003021A patent/MY188915A/en unknown
- 2009-04-29 EC EC2009009296A patent/ECSP099296A/es unknown
- 2009-04-29 CO CO09043396A patent/CO6220833A2/es active IP Right Grant
-
2010
- 2010-04-07 HK HK10103400.6A patent/HK1138181A1/zh unknown
-
2014
- 2014-01-27 RU RU2014102562A patent/RU2619555C2/ru active
- 2014-03-10 JP JP2014046094A patent/JP2014129413A/ja active Pending
-
2016
- 2016-06-22 JP JP2016123656A patent/JP6401744B2/ja active Active
-
2019
- 2019-11-11 US US16/679,908 patent/US11197894B2/en active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11197894B2 (en) | 2006-09-29 | 2021-12-14 | 4Life Patents, Llc | Nanofraction immune modulators, preparations and compositions including the same, and associated methods |
Also Published As
Publication number | Publication date |
---|---|
US10471100B2 (en) | 2019-11-12 |
RU2619555C2 (ru) | 2017-05-16 |
JP5592651B2 (ja) | 2014-09-17 |
EP2068913A2 (en) | 2009-06-17 |
ECSP099296A (es) | 2010-02-26 |
TW200831116A (en) | 2008-08-01 |
JP6401744B2 (ja) | 2018-10-10 |
MY188915A (en) | 2022-01-13 |
WO2008042604A2 (en) | 2008-04-10 |
JP2016196491A (ja) | 2016-11-24 |
JP2010504988A (ja) | 2010-02-18 |
MX2009003324A (es) | 2009-06-30 |
CN101553247A (zh) | 2009-10-07 |
US11197894B2 (en) | 2021-12-14 |
ES2658107T3 (es) | 2018-03-08 |
CO6220833A2 (es) | 2010-11-19 |
MY158857A (en) | 2016-11-15 |
TWI449530B (zh) | 2014-08-21 |
AU2007305076A1 (en) | 2008-04-10 |
US20200069737A1 (en) | 2020-03-05 |
EP2068913A4 (en) | 2009-12-02 |
JP2014129413A (ja) | 2014-07-10 |
AU2007305076B2 (en) | 2011-04-28 |
EP2068913B1 (en) | 2017-11-01 |
WO2008042604A3 (en) | 2008-11-06 |
RU2009116274A (ru) | 2010-11-10 |
RU2518341C2 (ru) | 2014-06-10 |
SG160430A1 (en) | 2010-04-29 |
US20080081076A1 (en) | 2008-04-03 |
RU2014102562A (ru) | 2015-08-20 |
CN101553247B (zh) | 2015-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1138181A1 (zh) | 免疫調節劑、含有免疫調節劑的組合物及其用途 | |
HRP20181353T1 (hr) | Tuberkulozni protein rv2386c, njegovi pripravci i upotreba | |
IL230759A0 (en) | Converted acyl anilide, the pharmaceutical composition containing it and its uses | |
PL2046405T3 (pl) | Biomateriały, ich wytwarzanie i zastosowanie | |
GB0601143D0 (en) | Uses, methods and compositions | |
ZA200810323B (en) | Fkbp-l and uses thereof | |
EP2124550A4 (en) | OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES, THEIR PREPARATION AND THEIR USE | |
IL211762A (en) | Pegillacie opioids, preparations containing them and their uses | |
ZA200901132B (en) | Human GLP-1 mimetibodies, compositions, methods and uses | |
SI2064327T1 (sl) | DBAIT in njegova uporaba | |
EP2101731A4 (en) | PROCESSES AND COMPOSITIONS WITH END OXIFES | |
GB0706077D0 (en) | Methods, Compositions and uses thereof | |
IL205966A0 (en) | Oligomer-tricyclic conjugates, compositions comprising the same and uses thereof | |
HK1133552A1 (zh) | 碳硼烷基卟啉及其用途 | |
GB0622399D0 (en) | Novel compositions and uses thereof | |
EP2088865A4 (en) | METHODS AND COMPOSITIONS AROUND GUGGULPHOSPHOLIPIDS | |
GB0617171D0 (en) | Novel compositions and methods | |
GB0819432D0 (en) | Compound, composition and use | |
EP1998753A4 (en) | COMPOSITIONS FOR MAJOR DEPOSITION AND USES THEREOF | |
EP2247303A4 (en) | HEMOSTASE MODULATING COMPOSITIONS AND USES THEREFOR | |
GB0715428D0 (en) | Compositions and uses thereof | |
IL208567A0 (en) | Oligomer-aryloxy-substituted propanamine conjugates, compositions comprising the same and uses thereof | |
GB0701170D0 (en) | Compositions and uses thereof | |
GB0622400D0 (en) | Novel compositions and uses thereof | |
EP2010141A4 (en) | HIGH DEPOSITION COMPOSITIONS AND USES THEREOF |